Riediger, A. L., Dietz, S., Schirmer, U., Meister, M., Heinzmann-Groth, I., Schneider, M., . . . Sültmann, H. (2016). Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients. Scientific reports, 6, . https://doi.org/10.1038/srep33505
Chicago Style (17th ed.) CitationRiediger, Anja Lisa, Steffen Dietz, Uwe Schirmer, Michael Meister, Ingrid Heinzmann-Groth, Marc Schneider, Thomas Muley, Michael Thomas, and Holger Sültmann. "Mutation Analysis of Circulating Plasma DNA to Determine Response to EGFR Tyrosine Kinase Inhibitor Therapy of Lung Adenocarcinoma Patients." Scientific Reports 6 (2016). https://doi.org/10.1038/srep33505.
MLA (9th ed.) CitationRiediger, Anja Lisa, et al. "Mutation Analysis of Circulating Plasma DNA to Determine Response to EGFR Tyrosine Kinase Inhibitor Therapy of Lung Adenocarcinoma Patients." Scientific Reports, vol. 6, 2016, https://doi.org/10.1038/srep33505.